
340B News & Regulatory Updates — September 2026
The Most Important 340B Developments of September 2026 Published by 340bprogram.com | September 30, 2026Sources: HRSA Office of Pharmacy Affairs, AHA, Fierce Healthcare, ACI Monthly
Published by 340bprogram.com | October 31, 2026
Sources: HRSA Office of Pharmacy Affairs, CMS, AHA, Supreme Court of the United States, Healthcare Finance News, Pharmaceutical Commerce, Health & Life Sciences News, 340B Report, Benesch, Mintz, Arkansas Attorney General, America’s Essential Hospitals
OCTOBER 2026 OVERVIEW
October turned the rebate pilot into a three-front fight: HRSA approved the manufacturers, hospitals sued again, and a House bill proposed a two-year delay. The full Fourth Circuit also heard the state contract pharmacy cases.
What it means for independent pharmacies: Plan for the rebate pilot to start January 1 unless a court or Congress stops it. Ask each covered-entity partner whether they received manufacturers’ 90-day notices and how your claims data will reach Beacon. Hospital partners now face lower Medicare payment on 340B drugs in 2027, so expect closer review of contract pharmacy fees.
When | What | Why it matters to a contract pharmacy |
|---|---|---|
October 1–15 | HRSA’s quarterly OPAIS registration window | Contract pharmacy arrangements registered now can start January 1, 2027 |
Early October | Manufacturers’ 90-day notices for the rebate pilot | Covered entities learn each manufacturer’s data and ordering instructions |
October 2 | Novartis’s extended deadline to seek Supreme Court review of the Mississippi ruling | A petition would put state contract pharmacy laws before the Court |
November (CMS’s usual timing) | Final 2027 Medicare outpatient rule | Decides whether the ASP minus 33.4% hospital payment cut takes effect |
No date set | En banc Fourth Circuit decision on West Virginia and Maryland | Decides whether a circuit split on state laws exists |
January 1, 2027 | Rebate pilot begins for 21 drugs | Partners pay full price up front and need clean claims data from you |
The American Hospital Association said after the approvals that it is weighing its options to stop the pilot, so a new court challenge is possible. Becker’s
Every item above links to the page it came from. These are the primary sources and trackers worth bookmarking for future monthly updates:
Several summaries rely on law-firm and trade-association write-ups of court rulings. Read the linked opinion or notice before acting on any item, and have counsel review anything that affects a contract.
Information in this update is provided for general educational purposes by 340bprogram.com, published by Medication Packaging Solutions LLC. Sources include HRSA, U.S. federal courts, Forvis Mazars, Feldesman Tucker, Quarles Law, HFMA, and other publicly available resources. This is not legal or compliance advice. For compliance-specific guidance, consult a qualified 340B compliance consultant or healthcare attorney. Published: November, 2026.

The Most Important 340B Developments of September 2026 Published by 340bprogram.com | September 30, 2026Sources: HRSA Office of Pharmacy Affairs, AHA, Fierce Healthcare, ACI Monthly

The Most Important 340B Developments of August 2026, Summarized in Plain English Published by 340bprogram.com | August 31, 2026Sources: HRSA Federal Register, Holland & Knight,

The Most Important 340B Developments of July 2026 Published by 340bprogram.com | July 31, 2026Sources: HRSA Federal Register, CMS, AHA, Covington & Burling, ArentFox Schiff,